The role of Ca 19-9 in progression, recurrence and survival of borderline resectable pancreatic cancer

被引：0
|
作者：
Almeida, C. [1 ]
Goncalves, M. [1 ]
Freitas, M. [1 ]
Teixeira, C. [1 ]
Couto, M. [1 ]
Lemos, T. [1 ]
Meireles, S. [1 ]
Rego, I. [1 ]
Sarmento, C. [1 ]
Coelho, A. [1 ]
Costa, A. [1 ]
Barbosa, M. [1 ]
机构：
[1] Ctr Hosp Sao Joao, Porto, Portugal
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.426
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-370
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 50 条
  • [31] Preoperative prediction of survival in resectable gallbladder cancer by a combined utilization of CA 19-9 and carcinoembryonic antigen
    Yu Tunan
    Yu Hong
    Cai Xiujun
    中华医学杂志（英文版）, 2014, (12) : 2299 - 2303
  • [32] Accuracy of CA 19-9 and Radiologic Imaging in Detecting Recurrence After Resection for Pancreatic Cancer
    Sperti, Cosimo
    Beltrame, Valentina
    Bissoli, Sergio
    Pedrazzoli, Sergio
    JOURNAL OF THE PANCREAS, 2013, 14 (06): : 680 - 681
  • [33] Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
    Tzeng, Ching-Wei D.
    Balachandran, Aparna
    Ahmad, Mediha
    Lee, Jeffrey E.
    Krishnan, Sunil
    Wang, Huamin
    Crane, Christopher H.
    Wolff, Robert A.
    Varadhachary, Gauri R.
    Pisters, Peter W. T.
    Aloia, Thomas A.
    Vauthey, Jean-Nicolas
    Fleming, Jason B.
    Katz, Matthew H. G.
    HPB, 2014, 16 (05) : 430 - 438
  • [34] Preoperative CA 19-9 Kinetics as a Prognostic Variable in Radiographically Resectable Pancreatic Adenocarcinoma
    Brown, E.
    Canter, R.
    Bold, R.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S99 - S100
  • [35] Is CA19-9 Response Following Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer an Early Surrogate for Eventual Survival Outcomes?
    Krishnan, S.
    Ahmad, M.
    Gonzalez, G. Noguera
    Das, P.
    Minsky, B.
    Delclos, M.
    Wolff, R.
    Fleming, J.
    Katz, M.
    Crane, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S312 - S312
  • [36] Preoperative CA 19-9 Kinetics as a Prognostic Variable in Radiographically Resectable Pancreatic Adenocarcinoma
    Brown, Erin G.
    Canter, Robert J.
    Bold, Richard J.
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (03) : 293 - 298
  • [37] CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma
    Ali C.W.
    Kaye T.F.
    Adamson D.J.A.
    Tait I.S.
    Polignano F.M.
    Highley M.S.
    Journal of Gastrointestinal Cancer, 2007, 38 (2-4) : 108 - 114
  • [38] THE SEROLOGIC MARKER CA 19-9 AND PANCREATIC-CANCER
    NARDONE, DA
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) : 184 - 185
  • [39] Exploring the role of CA 19-9 level as a predictor of survival in patients with advanced pancreatic adenocarcinoma
    Bekaii-Saab, T.
    Majumber, A.
    Trolli, E.
    Thomas, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 391 - 391
  • [40] CA 19-9 serum course and prognosis of pancreatic cancer
    Safi, F
    Schlosser, W
    Falkenreck, S
    Beger, HG
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1996, 20 (03) : 155 - 161
12345